Test Price
6,500 AED✅ Home Collection Available
Eukaryotic Transcriptome Sequencing and Reference‑Based Analysis (lncRNA Included) in the UAE | 6,500 AED | DHA Guidelines
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic‑grade sensitivity achieved via ISO‑accredited processing on Illumina NovaSeq platforms with full bioinformatic pipeline validation.
Premium Logistics: Hospital‑grade home collection using ISO‑certified cold‑chain transport and VIP mobile phlebotomy, available daily from 8 AM–11 PM.
Clinical Guidance: Complimentary post‑test telephonic consultation with a molecular geneticist to help interpret transcriptome and lncRNA findings.
Insurance: Direct billing verification and pre‑approval via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Eukaryotic Transcriptome Sequencing with lncRNA analysis maps the complete expression profile of all RNA transcripts – both coding (mRNA) and long non‑coding (lncRNA) – from your sample, providing unparalleled insight into gene regulation. This test is used in oncology, rheumatology, and biomedical research to identify disease‑associated biomarkers and guide personalised treatment strategies.
| Feature | Our Test – DHA‑Accredited | Closest Alternative (Research‑Only) |
|---|---|---|
| Precision | Deep sequencing (≥100 M paired‑end reads) + reference‑based lncRNA annotation | Often shallow coverage; lncRNA analysis not standardised |
| Methodology | Illumina NovaSeq RNA‑seq with advanced multi‑aligner bioinformatics (STAR, HISAT2) & lncRNA‑specific databases | Older sequencing platforms or microarray; limited ncRNA detection |
| Turnaround Time | 8 weeks – comprehensive report with clinical interpretation | 12–16 weeks in some external labs |
Physician Insight & Safety Protocols
“Transcriptome sequencing is a powerful exploratory tool, but it must be correlated with clinical findings, imaging, and standard laboratory markers. While it can reveal actionable tumour signatures or autoimmune pathways, no single gene expression change should dictate treatment alone. Always discuss your results with the referring clinician or our post‑test counsellor.”
– Dr. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License No. 9294403
⚠️ Medication Warning
Do not discontinue, adjust, or change any prescribed medication based solely on these results. Always consult your treating physician before making any therapeutic decisions.
🩺 Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide a high‑quality extracted DNA or fresh whole blood sample (volume <2 mL).
- Exclusion: Active systemic infection or recent blood transfusion (<2 weeks) that may affect RNA integrity.
- Red Flag: Sudden onset of new, progressive, or unexplained symptoms (e.g., rapidly growing mass, severe joint swelling, neurological changes) – seek immediate in‑person medical evaluation; do not wait for sequencing results.
- Red Flag: Paediatric patients: testing of minors requires explicit guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability. Contact us for protocol.
Patient FAQ & Clinical Guidance
1. What type of sample do I need to provide for transcriptome + lncRNA sequencing?
You can submit previously extracted DNA (preferred) or have our mobile phlebotomist collect a whole blood sample.
2. Is this test covered by health insurance in the UAE, and how can I verify?
Many UAE insurers cover transcriptome sequencing when medically necessary; contact our billing team on WhatsApp for real‑time eligibility check.
3. Why does the result take 8 weeks, and what does the report include?
The 8‑week timeframe allows deep bioinformatic analysis of billions of reads against reference genomes; your report lists differentially expressed genes, lncRNA annotations, and a clinical summary.
UAE Regulatory & Data Privacy Adherence
Your data is handled in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. DNA Labs UAE is licensed by the Dubai Health Authority (DHA Facility License No. 1143) and adheres to the highest standards of data security, confidentiality, and clinical governance. No genetic data is shared without your explicit consent.
Clinical & Logistical Metadata
| Attribute | Details |
|---|---|
| Test Name | Eukaryotic Transcriptome Sequencing (lncRNA Included) |
| Price (AED) | 6,500 AED |
| Turnaround Time | 8 weeks |
| Sample Type / Matrix | Whole blood (EDTA) or extracted DNA |
| Methodology Used | Illumina NovaSeq RNA‑seq with multi‑aligner bioinformatics (STAR, HISAT2) and lncRNA‑specific databases |
| ICD-10-CM Code | Z13.89 |
| LOINC Code | 94149-9 |
| DHA Facility License & Laboratory Address Invariants | DNA Labs UAE | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians